ITMI940298A0 - Uso del ceruletide (takus) nel trattamento della psoriasi - Google Patents

Uso del ceruletide (takus) nel trattamento della psoriasi

Info

Publication number
ITMI940298A0
ITMI940298A0 ITMI940298A ITMI940298A ITMI940298A0 IT MI940298 A0 ITMI940298 A0 IT MI940298A0 IT MI940298 A ITMI940298 A IT MI940298A IT MI940298 A ITMI940298 A IT MI940298A IT MI940298 A0 ITMI940298 A0 IT MI940298A0
Authority
IT
Italy
Prior art keywords
takus
ceruletide
psoriasis
treatment
Prior art date
Application number
ITMI940298A
Other languages
English (en)
Inventor
Keokharovna Kelesheva Lamara
Original Assignee
Theokhar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theokhar filed Critical Theokhar
Publication of ITMI940298A0 publication Critical patent/ITMI940298A0/it
Priority to ITMI940298A priority Critical patent/IT1274015B/it
Priority to IL11257895A priority patent/IL112578A0/xx
Priority to PL95311159A priority patent/PL311159A1/xx
Priority to HU9503295A priority patent/HU9503295D0/hu
Priority to ZA951137A priority patent/ZA951137B/xx
Priority to CA002160251A priority patent/CA2160251A1/en
Priority to EP95914489A priority patent/EP0696203A1/en
Priority to MX9504335A priority patent/MX9504335A/es
Priority to AU21465/95A priority patent/AU2146595A/en
Priority to PCT/IB1995/000282 priority patent/WO1995022346A1/en
Priority to FI954912A priority patent/FI954912A0/fi
Priority to JP7521701A priority patent/JPH08509245A/ja
Publication of ITMI940298A1 publication Critical patent/ITMI940298A1/it
Priority to NO954115A priority patent/NO954115L/no
Application granted granted Critical
Publication of IT1274015B publication Critical patent/IT1274015B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ITMI940298A 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi IT1274015B (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi
IL11257895A IL112578A0 (en) 1994-02-18 1995-02-08 Pharmaceutical compositions comprising ceruletide diethyl amine salt for the treatment of psoriasis
EP95914489A EP0696203A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
PCT/IB1995/000282 WO1995022346A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
ZA951137A ZA951137B (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
CA002160251A CA2160251A1 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
PL95311159A PL311159A1 (en) 1994-02-18 1995-02-13 Pharmaceutical composition for treating psoriasis
MX9504335A MX9504335A (es) 1994-02-18 1995-02-13 Uso de la sal de amina dietilica de ceruletida en el tratamiento de la psoriasis.
AU21465/95A AU2146595A (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
HU9503295A HU9503295D0 (en) 1994-02-18 1995-02-13 Use of ceruletide diethyl amine salt in the treatment of psoriasis
FI954912A FI954912A0 (fi) 1994-02-18 1995-02-13 Keruletidin dietyyliamiinisuolan käyttö psoriaasin hoidossa
JP7521701A JPH08509245A (ja) 1994-02-18 1995-02-13 乾癬の治療におけるセルレチドジエチルアミン塩の使用
NO954115A NO954115L (no) 1994-02-18 1995-10-16 Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi

Publications (3)

Publication Number Publication Date
ITMI940298A0 true ITMI940298A0 (it) 1994-02-18
ITMI940298A1 ITMI940298A1 (it) 1995-08-19
IT1274015B IT1274015B (it) 1997-07-14

Family

ID=11367909

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI940298A IT1274015B (it) 1994-02-18 1994-02-18 Uso del ceruletide (takus) nel trattamento della psoriasi

Country Status (13)

Country Link
EP (1) EP0696203A1 (it)
JP (1) JPH08509245A (it)
AU (1) AU2146595A (it)
CA (1) CA2160251A1 (it)
FI (1) FI954912A0 (it)
HU (1) HU9503295D0 (it)
IL (1) IL112578A0 (it)
IT (1) IT1274015B (it)
MX (1) MX9504335A (it)
NO (1) NO954115L (it)
PL (1) PL311159A1 (it)
WO (1) WO1995022346A1 (it)
ZA (1) ZA951137B (it)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034531C2 (de) * 1980-09-12 1986-09-18 Farmitalia Carlo Erba S.p.A., Mailand/Milano Verwendung von Polypeptiden als Analgetikum in der Human- und Tiermedizin
JPS6041052B2 (ja) * 1981-04-07 1985-09-13 塩野義製薬株式会社 向精神薬

Also Published As

Publication number Publication date
AU2146595A (en) 1995-09-04
ITMI940298A1 (it) 1995-08-19
WO1995022346A1 (en) 1995-08-24
NO954115D0 (no) 1995-10-16
CA2160251A1 (en) 1995-08-24
FI954912A7 (fi) 1995-10-16
PL311159A1 (en) 1996-02-05
ZA951137B (en) 1995-12-01
HU9503295D0 (en) 1996-01-29
IL112578A0 (en) 1995-05-26
FI954912L (fi) 1995-10-16
JPH08509245A (ja) 1996-10-01
MX9504335A (es) 1997-05-31
EP0696203A1 (en) 1996-02-14
IT1274015B (it) 1997-07-14
NO954115L (no) 1995-10-16
FI954912A0 (fi) 1995-10-16

Similar Documents

Publication Publication Date Title
ITBO910163A0 (it) Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica
DE3880923D1 (de) Perkutaner absorptionspromotor und dermatologische zusammensetzung fuer externe anwendung.
IT8223892A0 (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle.
ITMI932412A1 (it) Uso di alfa 1-bloccanti nel trattamento della eiaculazione precoce
ATA219891A (de) Inlett in gewebebindung
ITMI912509A0 (it) Uso della nimesulide nel trattamento della cataratta
IT1252603B (it) 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
BR9709636A (pt) Uso de buckminsterfulereno no tratamento de ferimento neurotóxico
FI896059A7 (fi) Hoitopenkki
ITMI940298A0 (it) Uso del ceruletide (takus) nel trattamento della psoriasi
IT9041598A0 (it) Nuovo uso terapeutico del dipiridamolo
IT1163107B (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma
ITPD910234A0 (it) Uso terapeutico del gaglioside gm1 nel trattamento del danno al midollo spinale
IT1284920B1 (it) Trattamento del diamante
FI962506L (fi) Psoriasiksen hoito
ITMI941064A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete
IT1282952B1 (it) Formulazioni farmaceutiche gastroresistenti contenenti colostro e uso del colostro per il trattamento della costipazione
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
ITUD910171A1 (it) Apparecchio perfezionato per il trattamento della vigna ed in particolare della botrite
DK0734514T3 (da) Vævsprøvebehandling
ITFI930069A0 (it) Uso orale e topico della n-acetil-5-metossitriptamina (melatonina) nella terapia della psoriasi volgare.
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
ITMI950773A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete mellito
ITMI931800A0 (it) Uso della 4 -desossi-4-iododoxorubicina per il trattamento della alamiloidosi

Legal Events

Date Code Title Description
0001 Granted